Χωρίς κατηγορία

Pharmazac launched the new product  Vasitimb / ezetimibe + simvastatin for theprevention of cardiovascular events, for hypercholesterlaemia and for theHomozygous Familial Hypercholesterolaemia. Therapeutic Indications Prevention of Cardiovascular Events Vasitimb is indicated to reduce the risk of cardiovascular events  in patients with coronary heart disease (CHD) and a history of acute coronary syndrome...